首页> 美国卫生研究院文献>Journal of Clinical Laboratory Analysis >Effect of Asian ginseng Siberian ginseng and Indian ayurvedic medicine Ashwagandha on serum digoxin measurement by digoxin III a new digoxin immunoassay
【2h】

Effect of Asian ginseng Siberian ginseng and Indian ayurvedic medicine Ashwagandha on serum digoxin measurement by digoxin III a new digoxin immunoassay

机译:亚洲人参西伯利亚人参和印度阿育吠陀药Ashwagandha对地高辛免疫测定新方法地高辛III测定地高辛的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Asian ginseng, Siberian ginseng, and Indian Ayurvedic medicine Ashwagandha demonstrated modest interference with serum digoxin measurements by the fluorescent polarization immunoassay (FPIA). Recently, Abbott Laboratories marketed a new digoxin immunoassay, Digoxin III for application on the AxSYM analyzer. We studied potential interference of these herbal supplements on serum digoxin measurement by Digoxin III assay in vitro and compared our results with the values obtained by Tina‐quant assay. Aliquots of drug‐free serum pool were supplemented with various amounts of Asian ginseng, Siberian ginseng, or Ashwagandha approximating expected concentrations after recommended doses and overdoses of these herbal supplements in serum. Then digoxin concentrations were measured by the Digoxin III and Tina‐quant (Roche Diagnostics) assay. We also supplemented aliquots of a digoxin pool prepared from patients receiving digoxin with various amounts of these herbal supplements and then measured digoxin concentrations again using both digoxin immunoassays. We observed modest apparent digoxin concentrations when aliquots of drug‐free serum pool were supplemented with all three herbal supplements using Digoxin III assay (apparent digoxin in the range of 0.31–0.57 ng/ml), but no apparent digoxin concentration (except with the highest concentration of Ashwagandha supplement for both brands) was observed using the Tina‐quant assay. When aliquots of digoxin pool were further supplemented with these herbal supplements, digoxin concentrations were falsely elevated when measured by the new Digoxin III assay. For example, we observed 48.2% (1.63 ng/ml digoxin) increase in digoxin concentration when an aliquot of Digoxin pool 1 (1.10 ng/ml digoxin) was supplemented with 50 μl of Asian ginseng extract (Brand 2). Measuring free digoxin does not eliminate the modest interferences of these herbal supplements in serum digoxin measurement by the Digoxin III assay. J. Clin. Lab. Anal. 22:295–301, 2008. © 2008 Wiley‐Liss, Inc.
机译:亚洲人参,西伯利亚人参和印度阿育吠陀药Ashwagandha通过荧光偏振免疫分析(FPIA)对血清地高辛的测定显示出适度的干扰。最近,雅培实验室销售了一种新的地高辛免疫测定方法,即地高辛III型,可用于AxSYM分析仪。我们在体外研究了这些草药补品对地高辛III测定法对血清地高辛测定的潜在干扰,并将我们的结果与Tina-quant法获得的值进行了比较。在等剂量的无药血清中补充了各种量的亚洲人参,西伯利亚人参或Ashwagandha,在推荐剂量和过量服用这些草药补充剂后,其预期浓度接近预期。然后通过Digoxin III和Tinaquant(Roche Diagnostics)测定法测定地高辛浓度。我们还为接受地高辛的患者准备的地高辛库的等分试样补充了各种量的这些草药补品,然后使用两种地高辛免疫测定法再次测量了地高辛的浓度。当我们使用地高辛III分析法(全部地高辛地高辛在0.31–0.57 ng / ml范围内)对所有三种草药补品等分的无药血清合并时,我们观察到适度的地高辛浓度,但没有明显的地高辛浓度(最高的除外)使用Tina-quant分析观察了两个品牌的Ashwagandha补充剂的浓度。当用这些草药补品进一步补充地高辛库的等分试样时,用新的地高辛III测定法测定地高辛浓度会错误地升高。例如,我们观察到当等分试样的地高辛库1(1.10ng / ml地高辛)补充50μl亚洲人参提取物(品牌2)时,地高辛浓度增加48.2%(1.63μng/ ml地高辛)。测量游离地高辛不能通过Digoxin III测定消除这些草药补品对血清地高辛测量的适度干扰。 J.临床实验室肛门22:295–301,2008年。©2008 Wiley-Liss,Inc.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号